PP
ELV icon

Paloma Partners’s Elevance Health ELV Stock Holding History

Paloma Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,200
Closed -$3.36M – 1312
2024
Q2 		$3.36M Buy
6,200
+452
+8% +$239K 0.09% 229
2024
Q1 		$2.98M Buy
5,748
+3,948
+219% +$1.96M 0.16% 157
2023
Q4 		$849K Buy
1,800
+600
+50% +$277K 0.03% 446
2023
Q3 		$523K Buy
+1,200
New +$544K 0.02% 477
2023
Q1 		– Sell
-2,600
Closed -$1.33M – 813
2022
Q4 		$1.33M Buy
+2,600
New +$1.32M 0.06% 302
2022
Q2 		– Sell
-8,500
Closed -$4.17M – 1282
2022
Q1 		$4.17M Buy
8,500
+7,100
+507% +$3.25M 0.12% 106
2021
Q4 		$649K Buy
+1,400
New +$589K 0.01% 966
2021
Q1 		– Sell
-19,600
Closed -$6.29M – 2113
2020
Q4 		$6.29M Buy
+19,600
New +$6.01M 0.17% 127
2020
Q3 		– Sell
-15,000
Closed -$3.94M – 2177
2020
Q2 		$3.94M Buy
+15,000
New +$4M 0.07% 377
2020
Q1 		– Sell
-4,400
Closed -$1.33M – 1461
2019
Q4 		$1.33M Sell
4,400
-9,400
-68% -$2.59M 0.02% 810
2019
Q3 		$3.31M Buy
+13,800
New +$3.78M 0.07% 243
2019
Q2 		– Sell
-5,000
Closed -$1.44M – 1844
2019
Q1 		$1.44M Buy
+5,000
New +$1.45M 0.03% 568
2018
Q2 		– Sell
-3,000
Closed -$659K – 1760
2018
Q1 		$659K Sell
3,000
-20,600
-87% -$4.84M 0.01% 1215
2017
Q4 		$5.31M Buy
23,600
+19,800
+521% +$4.22M 0.07% 266
2017
Q3 		$722K Sell
3,800
-47,100
-93% -$8.96M 0.01% 1332
2017
Q2 		$9.58M Buy
50,900
+26,400
+108% +$4.74M 0.11% 144
2017
Q1 		$4.05M Buy
+24,500
New +$3.9M 0.05% 401

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Paloma Partners's ELV Position: Q4 2024 in Review

Paloma Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 2,264 shares — an estimated $1.18M sold.

Paloma Partners first reported a position in ELV in Q2 2013 and held it in 36 quarters. The position peaked at $9.99M in Q4 2017. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Paloma Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 2,264 Elevance Health shares in Q4 2024, an estimated $1.18M.
  • Paloma Partners first reported a position in Elevance Health in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Elevance Health position peaked at $9.99M in Q4 2017.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.